Priorix

SKU: PRIORIX-GSK Categories: , , , Tags: , , ,

Description

PRIORIX is a lyophilised mixed preparation containing the attenuated live Measles, Mumps and Rubella virus strain propagated in either chick embryo tissue cultures (mumps and measles) or human diploid cells (rubella). PRIORIX is indicated for active immunization in children of 12 months to 10 years of age against Measles, Mumps and Rubella infections simultaneously.

Immunization guideline:

A reconstituted dose of 0.5mL is recommended for children and adults.

Children: Two doses are usually given. The first dose is usually given at 12 months of age, followed by a booster dose at 4-6 years of age

Adults: A single dose may be given to adults who do not have immunity.

For latest IAP updates see revised immunization schedule.

Additional information

vaccine-type

Measles, Mumps and Rubella

manufacturer

GlaxoSmithKline

country-of-manufacture

Belgium

pharmaceutical-form

Lyophilized

package-size

1 Dose

route-of-administration

Intramuscular, Subcutaneous

preservative

None

Contraindications

Pregnancy, hypersensitivity to any components of the vaccine, allergy to neomycin, acute severe febrile illness and impaired immune response. The presence of a minor infection, however, is not a contraindication.